Los Angeles Capital Management & Equity Research Inc. trimmed its position in shares of MetLife, Inc. (NYSE:MET) by 46.4% during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 633,823 shares of the financial services provider’s stock after selling 548,715 shares during the quarter. Los Angeles Capital Management & Equity Research Inc. owned about 0.06% of MetLife worth $34,822,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. First Personal Financial Services grew its position in MetLife by 11.5% during the 1st quarter. First Personal Financial Services now owns 2,588 shares of the financial services provider’s stock valued at $137,000 after purchasing an additional 266 shares during the last quarter. Westside Investment Management Inc. grew its position in MetLife by 583.8% during the 1st quarter. Westside Investment Management Inc. now owns 2,694 shares of the financial services provider’s stock valued at $140,000 after purchasing an additional 2,300 shares during the last quarter. Parallel Advisors LLC grew its position in MetLife by 50.7% during the 1st quarter. Parallel Advisors LLC now owns 2,748 shares of the financial services provider’s stock valued at $143,000 after purchasing an additional 924 shares during the last quarter. First Mercantile Trust Co. grew its position in MetLife by 3.4% during the 2nd quarter. First Mercantile Trust Co. now owns 2,926 shares of the financial services provider’s stock valued at $161,000 after purchasing an additional 97 shares during the last quarter. Finally, CI Investments Inc. purchased a new stake in MetLife during the 1st quarter valued at about $158,000. 74.14% of the stock is currently owned by institutional investors.

MetLife, Inc. (NYSE MET) opened at 49.47 on Wednesday. MetLife, Inc. has a 12-month low of $38.17 and a 12-month high of $51.77. The company has a 50 day moving average of $47.80 and a 200-day moving average of $47.30. The stock has a market cap of $52.58 billion, a P/E ratio of 582.00 and a beta of 1.44.

MetLife (NYSE:MET) last issued its earnings results on Wednesday, August 2nd. The financial services provider reported $1.30 EPS for the quarter, beating the Zacks’ consensus estimate of $1.28 by $0.02. The firm had revenue of $17.39 billion for the quarter, compared to analyst estimates of $17.11 billion. MetLife had a return on equity of 8.51% and a net margin of 0.30%. MetLife’s revenue for the quarter was up 2.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.83 earnings per share. Equities analysts forecast that MetLife, Inc. will post $4.78 earnings per share for the current year.

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 13th. Investors of record on Monday, August 7th were given a $0.40 dividend. The ex-dividend date was Thursday, August 3rd. This represents a $1.60 dividend on an annualized basis and a yield of 3.23%. MetLife’s dividend payout ratio is currently 1,777.98%.

COPYRIGHT VIOLATION WARNING: This piece of content was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece of content on another website, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/09/20/metlife-inc-met-position-reduced-by-los-angeles-capital-management-equity-research-inc.html.

Several analysts recently commented on the stock. Wells Fargo & Company reissued a “buy” rating on shares of MetLife in a research report on Saturday, July 1st. Langen Mcalenn reissued a “buy” rating on shares of MetLife in a research report on Wednesday, August 16th. J P Morgan Chase & Co assumed coverage on shares of MetLife in a research report on Monday, July 24th. They set a “hold” rating and a $78.00 price objective on the stock. Royal Bank Of Canada reissued a “buy” rating and set a $62.00 price objective on shares of MetLife in a research report on Wednesday, July 12th. Finally, Keefe, Bruyette & Woods reissued a “buy” rating and set a $59.00 price objective on shares of MetLife in a research report on Thursday, August 3rd. Two research analysts have rated the stock with a sell rating, six have given a hold rating and ten have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of $57.95.

MetLife Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Stock Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related stocks with our FREE daily email newsletter.